{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:04:04Z","timestamp":1759147444569,"version":"3.41.2"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004343","name":"Stavros Niarchos Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00800","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:20:06Z","timestamp":1541118006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Regenerative Approaches in Huntington\u2019s Disease: From Mechanistic Insights to Therapeutic Protocols"],"prefix":"10.3389","volume":"12","author":[{"given":"Jenny","family":"Sassone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Thomaidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.stemcr.2018.03.007","article-title":"hPSC-Derived Striatal Cells Generated Using a Scalable 3D Hydrogel Promote Recovery in a Huntington Disease Mouse Model.","volume":"10","author":"Adil","year":"2018","journal-title":"Stem Cell Reports"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1242\/dev.117093","article-title":"Activin A directs striatal projection neuron differentiation of human pluripotent stem cells.","volume":"142","author":"Arber","year":"2015","journal-title":"Development"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00382","article-title":"Intracellular cholesterol trafficking and impact in neurodegeneration.","volume":"10","author":"Arenas","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington\u2019s disease.","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease.","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1242\/dev.084608","article-title":"Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons.","volume":"140","author":"Carri","year":"2013","journal-title":"Development"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/stem.1430","article-title":"High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.","volume":"31","author":"Charbord","year":"2013","journal-title":"Stem Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","article-title":"PPARgamma rescue of the mitochondrial dysfunction in Huntington\u2019s disease.","volume":"45","author":"Chiang","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1172\/JCI31778","article-title":"Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.","volume":"117","author":"Cho","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E762","DOI":"10.1073\/pnas.1715865115","article-title":"Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.","volume":"115","author":"Conforti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jnc.12348","article-title":"Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington\u2019s disease models.","volume":"127","author":"Conforti","year":"2013","journal-title":"J. Neurochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/stem.2747","article-title":"Concise review: the use of stem cells for understanding and treating Huntington\u2019s Disease.","volume":"36","author":"Connor","year":"2018","journal-title":"Stem Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.410270217","article-title":"Degeneration of pyramidal projection neurons in Huntington\u2019s disease cortex.","volume":"27","author":"Cudkowicz","year":"1990","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease.","volume":"27","author":"Desplats","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cell.2014.01.044","article-title":"Neurogenesis in the striatum of the adult human brain.","volume":"156","author":"Ernst","year":"2014","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E1234","DOI":"10.1073\/pnas.1611473114","article-title":"Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1.","volume":"114","author":"Faedo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.stem.2015.12.003","article-title":"Identification and successful negotiation of a metabolic checkpoint in direct neuronal reprogramming.","volume":"18","author":"Gasc\u00f3n","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nbd.2015.09.008","article-title":"Mitochondrial dynamics and quality control in Huntington\u2019s disease.","volume":"90","author":"Guedes-Dias","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911DS1","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington\u2019 s disease \u2013 associated neurodegeneration.","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12646","article-title":"VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease.","volume":"7","author":"Guo","year":"2016","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.stem.2013.12.001","article-title":"In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer\u2019s disease model.","volume":"14","author":"Guo","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.stemcr.2014.10.007","article-title":"Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex.","volume":"3","author":"Heinrich","year":"2014","journal-title":"Stem Cell Reports"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000373","article-title":"Directing astroglia from the cerebral cortex into subtype specific functional neurons.","volume":"8","author":"Heinrich","year":"2010","journal-title":"PLoS Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells.","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"B25","doi-asserted-by":"publisher","first-page":"18189","DOI":"10.1073\/pnas.0506375102","article-title":"FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington\u2019s disease.","volume":"102","author":"Jin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","article-title":"Gene dysregulation in Huntington\u2019s disease: REST, microRNAs and beyond.","volume":"11","author":"Johnson","year":"2009","journal-title":"Neuromolecular Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116069","article-title":"Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of huntington\u2019s disease is accompanied by striatal invasion of neuroblasts.","volume":"10","author":"Kandasamy","year":"2015","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-114","article-title":"Impaired adult olfactory bulb neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"11","author":"Kohl","year":"2010","journal-title":"BMC Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of huntington\u2019s disease by transient repression of huntingtin synthesis.","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14802\/jmd.16054","article-title":"Exosome-based delivery of miR-124 in a Huntington\u2019s Disease model.","volume":"10","author":"Lee","year":"2017","journal-title":"J. Mov. Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice.","volume":"20","author":"Lim","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bbrc.2016.09.065","article-title":"Energy defects in Huntington\u2019s disease: Why \u201cin vivo\u201d evidence matters.","volume":"483","author":"Liot","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4103\/1673-5374.156978","article-title":"MicroRNA-124 slows down the progression of huntington\u2019s disease by promoting neurogenesis in the striatum.","author":"Liu","year":"2015","journal-title":"Neural Regen. Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025088","article-title":"New striatal neurons in a mouse model of progressive striatal degeneration are generated in both the subventricular zone and the striatal parenchyma.","volume":"6","author":"Luzzati","year":"2011","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","article-title":"Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.","volume":"10","author":"Ma","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes.","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.346.6206.237","article-title":"A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse.","volume":"346","author":"Magnusson","year":"2014","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41593-018-0086-4","article-title":"Huntington modeling improves with age.","volume":"21","author":"Mattis","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","article-title":"Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects.","volume":"17","author":"Mertens","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ymthe.2018.02.002","article-title":"Translation of MicroRNA-based huntingtin-lowering therapies from preclinical studies to the clinic.","volume":"26","author":"Miniarikova","year":"2018","journal-title":"Mol. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","article-title":"AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease.","volume":"24","author":"Miniarikova","year":"2017","journal-title":"Gene Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1242\/dev.116657","article-title":"Striatal astrocytes produce neuroblasts in an excitotoxic model of Huntington\u2019s disease.","volume":"142","author":"Nato","year":"2015","journal-title":"Development"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/ncb2843","article-title":"In vivo reprogramming of astrocytes to neuroblasts in the adult brain.","volume":"15","author":"Niu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9\u2217 regulates REST and CoREST and is downregulated in Huntington\u2019s disease.","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells.","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000004844","article-title":"MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.","volume":"90","author":"Reed","year":"2017","journal-title":"Neurology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nbt.3835","article-title":"Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson\u2019s disease model.","volume":"35","author":"Rivetti Di Val Cervo","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice.","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1242\/dev.156844","article-title":"Chromosomal instability during neurogenesis in Huntington\u2019s disease.","volume":"142","author":"Ruzo","year":"2018","journal-title":"Development"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.300","article-title":"Defining the role of the Bcl-2 family proteins in Huntington\u2019s disease.","volume":"4","author":"Sassone","year":"2013","journal-title":"Cell Death Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","article-title":"What have we learned from gene expression profiles in Huntington\u2019s disease?","volume":"45","author":"Seredenina","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1093\/hmg\/ddw316","article-title":"A small molecule p75NTRligand normalizes signalling and reduces Huntington\u2019s disease phenotypes in R6\/2 and BACHD mice.","volume":"25","author":"Simmons","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6\/2 and BACHD Mouse Models of Huntington\u2019s Disease.","volume":"33","author":"Simmons","year":"2013","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(10)70160-5","article-title":"Uncovering the true prevalence of Huntington\u2019s disease.","volume":"9","author":"Spinney","year":"2010","journal-title":"Lancet Neurol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00193","article-title":"An updated role of microRNA-124 in central nervous system disorders: a review.","volume":"9","author":"Sun","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1242\/dmm.019406","article-title":"Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.","volume":"8","author":"Szlachcic","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"B60","article-title":"Effects of IONIS-HTTRx in patients with early Huntington\u2019s disease, results of the first HTT-lowering drug trial (CT.002).","author":"Tabrizi","year":"2018","journal-title":"Paper presented at the 2018 American Academy of Neurology Annual Meeting"},{"key":"B61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neubiorev.2017.02.017","article-title":"Regenerative medicine in Huntington\u2019s disease: Strengths and weaknesses of preclinical studies.","volume":"77","author":"Tartaglione","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes.","volume":"11","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.celrep.2015.06.040","article-title":"Invivo reprogramming of striatal NG2 glia into functional neurons that integrate into local host circuitry.","volume":"12","author":"Torper","year":"2015","journal-title":"Cell Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1073\/pnas.1303829110","article-title":"Generation of induced neurons via direct conversion in vivo.","volume":"10","author":"Torper","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","article-title":"Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice.","volume":"7","author":"Valenza","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","article-title":"Generation of human striatal neurons by microrna-dependent direct conversion of fibroblasts.","volume":"84","author":"Victor","year":"2014","journal-title":"Neuron"},{"key":"B67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41593-018-0075-7","article-title":"Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes.","volume":"21","author":"Victor","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1101\/gad.1519107","article-title":"The microRNA miR-124 antagonizes the anti-neural REST\/SCP1 pathway during embryonic CNS development.","volume":"21","author":"Visvanathan","year":"2007","journal-title":"Genes Dev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1007\/s12035-017-0477-7","article-title":"Huntington disease as a neurodevelopmental disorder and early signs of the disease in stem cells.","volume":"55","author":"Wiatr","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington\u2019s disease: What\u2019s in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov. Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","article-title":"Exosome mediated delivery of miR-124 promotes neurogenesis after Ischemia.","volume":"7","author":"Yang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","article-title":"Huntington\u2019s Disease.","volume":"220","author":"Zuccato","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease.","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:20:09Z","timestamp":1541118009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":73,"alternative-id":["10.3389\/fnins.2018.00800"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00800","relation":{},"ISSN":["1662-453X"],"issn-type":[{"type":"electronic","value":"1662-453X"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"article-number":"800"}}